|
Prequalification Update - 30 August 2007
 WHO
Prequalification Programme adds 5 new HIV/AIDS products
to its list of prequalified medicines
The 5 new products added to the list of
prequalified HIV/AIDS products are as follows:
- Lamivudine/Stavudine
150mg/30mg Tablets Cipla Ltd
HDPE bottle 60
-
Lamivudine/Stavudine
150mg/40mg Tablets Cipla Ltd
HDPE bottle 60
-
Lamivudine/Stavudine + Efavirenz
150mg/30mg + 600mg Tablets Ranbaxy
Laboratories Ltd Alu/Alu blister 2 + 1;
Cardboard box 30 + 15
-
Lamivudine/Stavudine + Efavirenz
150mg/40mg + 600mg Tablets Ranbaxy
Laboratories Ltd Alu/Alu blister 2 + 1;
Cardboard box 30 + 15
-
Lamivudine/Zidovudine + Efavirenz
150mg/300mg + 600mg Tablets Ranbaxy
Laboratories Ltd Alu/Alu blister 2 + 1;
Cardboard box 30 + 15
Related Link:
57th
Edition List of HIV/AIDS Prequalified Products and
Manufacturers
WHO
Prequalification Programme adds 3 new malaria products to its
list of prequalified medicines
The 3 new products added to the list of
prequalified malaria products are as follows:
- Amodiaquine 150mg Film-coated tablets Guilin Pharmaceutical Co., Ltd
PVC/Alu blisters 6; Cardboard box 2 x 6
- Artesunate +
Amodiaquine 50mg + 150mg tablets Guilin
Pharmaceutical Co., Ltd PVC blisters sealed
with an aluminium foil lid 4 + 4; Cardboard box 3 x
(4 + 4)
- Artesunate
50mg Tablets
Ipca Laboratories Ltd
PVdC/Alu 12
The SPC (Summary of Product Characteristics)
for amodiaquine 150mg film-coated tablets is published on the
WHOPAR page. The corresponding Patient Information
Leaflet (PIL) is under development.
The SPC for artesunate +
amodiaquine 50mg + 150mg co-blistered tablets including
a restricted therapeutic indication, as well as the
corresponding PIL are under development.
Related Link:
6th
Edition List of Malaria Prequalified Products and
Manufacturers
|
Home >> Prequalification Update
- 30 August 2007